These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 30641023

  • 21. Genetic and antigenic typing of seasonal influenza virus breakthrough cases from a 2008-2009 vaccine efficacy trial.
    Durviaux S, Treanor J, Beran J, Duval X, Esen M, Feldman G, Frey SE, Launay O, Leroux-Roels G, McElhaney JE, Nowakowski A, Ruiz-Palacios GM, van Essen GA, Oostvogels L, Devaster JM, Walravens K.
    Clin Vaccine Immunol; 2014 Mar; 21(3):271-9. PubMed ID: 24371255
    [Abstract] [Full Text] [Related]

  • 22. Molecular analysis of isolates from influenza B outbreaks in the U.S. and Nepal, 2005.
    Daum LT, Canas LC, Klimov AI, Shaw MW, Gibbons RV, Shrestha SK, Myint KS, Acharya RP, Rimal N, Reese F, Niemeyer DM, Arulanandam BP, Chambers JP.
    Arch Virol; 2006 Sep; 151(9):1863-74. PubMed ID: 16736092
    [Abstract] [Full Text] [Related]

  • 23. Substitutions near the HA receptor binding site explain the origin and major antigenic change of the B/Victoria and B/Yamagata lineages.
    Rosu ME, Lexmond P, Bestebroer TM, Hauser BM, Smith DJ, Herfst S, Fouchier RAM.
    Proc Natl Acad Sci U S A; 2022 Oct 18; 119(42):e2211616119. PubMed ID: 36215486
    [Abstract] [Full Text] [Related]

  • 24. Increasing appearance of reassortant influenza B virus in Taiwan from 2002 to 2005.
    Tsai HP, Wang HC, Kiang D, Huang SW, Kuo PH, Liu CC, Su IJ, Wang JR.
    J Clin Microbiol; 2006 Aug 18; 44(8):2705-13. PubMed ID: 16891481
    [Abstract] [Full Text] [Related]

  • 25. Development of neutralizing monoclonal antibodies against the pandemic H1N1 virus (2009) using plasmid DNA immunogen.
    Cabral TM, Baig A, Berhane Y, Schmidt L, Hole K, Leith M, Kobasa D, Corbett CR.
    J Virol Methods; 2014 Jan 18; 195():54-62. PubMed ID: 24060631
    [Abstract] [Full Text] [Related]

  • 26. Epitope mapping of the hemagglutinin molecule of a highly pathogenic H5N1 influenza virus by using monoclonal antibodies.
    Kaverin NV, Rudneva IA, Govorkova EA, Timofeeva TA, Shilov AA, Kochergin-Nikitsky KS, Krylov PS, Webster RG.
    J Virol; 2007 Dec 18; 81(23):12911-7. PubMed ID: 17881439
    [Abstract] [Full Text] [Related]

  • 27. Divergent evolutionary trajectories of influenza B viruses underlie their contemporaneous epidemic activity.
    Virk RK, Jayakumar J, Mendenhall IH, Moorthy M, Lam P, Linster M, Lim J, Lin C, Oon LLE, Lee HK, Koay ESC, Vijaykrishna D, Smith GJD, Su YCF.
    Proc Natl Acad Sci U S A; 2020 Jan 07; 117(1):619-628. PubMed ID: 31843889
    [Abstract] [Full Text] [Related]

  • 28. A novel humanized antibody neutralizes H5N1 influenza virus via two different mechanisms.
    Tan Y, Ng Q, Jia Q, Kwang J, He F.
    J Virol; 2015 Apr 07; 89(7):3712-22. PubMed ID: 25609802
    [Abstract] [Full Text] [Related]

  • 29. Heterogeneity of influenza B virus strains in one epidemic season differentiated by monoclonal antibodies and nucleotide sequences.
    Nakagawa N, Kubota R, Maeda A, Nakagawa T, Okuno Y.
    J Clin Microbiol; 2000 Sep 07; 38(9):3467-9. PubMed ID: 10970406
    [Abstract] [Full Text] [Related]

  • 30. [Detection of conservative and variable epitopes of the pandemic influenza virus A(H1N1)pdm09 hemagglutinin using monoclonal antibodies].
    Masalova OV, Chichev EV, Fediakina IT, Mukasheva EA, Klimova RR, Shchelkanov MIu, Burtseva EI, Ivanova VT, Kushch AA, L'vov DK.
    Vopr Virusol; 2014 Sep 07; 59(3):34-40. PubMed ID: 25335417
    [Abstract] [Full Text] [Related]

  • 31. [Epidemic strains influenza viruses A and B in the 2005-2006 season in Russia].
    Ivanova VT, Matiushina RO, Slepushkin AN, Burtseva EI, Oskerko TA, Shevchenko ES, Trushakova SV, Kurochkina IaE, Zagorskaia IuN, Cherkasov EG, Merkulova LN, Feodoritova EL.
    Vopr Virusol; 2008 Sep 07; 53(4):13-8. PubMed ID: 18756810
    [Abstract] [Full Text] [Related]

  • 32. Genetic diversity of influenza B virus: the frequent reassortment and cocirculation of the genetically distinct reassortant viruses in a community.
    Matsuzaki Y, Sugawara K, Takashita E, Muraki Y, Hongo S, Katsushima N, Mizuta K, Nishimura H.
    J Med Virol; 2004 Sep 07; 74(1):132-40. PubMed ID: 15258979
    [Abstract] [Full Text] [Related]

  • 33. Human monoclonal antibodies broadly neutralizing against influenza B virus.
    Yasugi M, Kubota-Koketsu R, Yamashita A, Kawashita N, Du A, Sasaki T, Nishimura M, Misaki R, Kuhara M, Boonsathorn N, Fujiyama K, Okuno Y, Nakaya T, Ikuta K.
    PLoS Pathog; 2013 Feb 07; 9(2):e1003150. PubMed ID: 23408886
    [Abstract] [Full Text] [Related]

  • 34. A multimechanistic antibody targeting the receptor binding site potently cross-protects against influenza B viruses.
    Shen C, Chen J, Li R, Zhang M, Wang G, Stegalkina S, Zhang L, Chen J, Cao J, Bi X, Anderson SF, Alefantis T, Zhang M, Cai X, Yang K, Zheng Q, Fang M, Yu H, Luo W, Zheng Z, Yuan Q, Zhang J, Wai-Kuo Shih J, Kleanthous H, Chen H, Chen Y, Xia N.
    Sci Transl Med; 2017 Oct 18; 9(412):. PubMed ID: 29046433
    [Abstract] [Full Text] [Related]

  • 35. Antigenic and genetic analyses of influenza B viruses isolated in Lusaka, Zambia in 1999.
    Muyanga J, Matsuzaki Y, Sugawara K, Kimura K, Mizuta K, Ndumba I, Muraki Y, Tsuchiya E, Hongo S, Kasolo FC, Numazaki Y, Nakamura K.
    Arch Virol; 2001 Oct 18; 146(9):1667-79. PubMed ID: 11699954
    [Abstract] [Full Text] [Related]

  • 36. Evolutionary pattern of reemerging influenza B/Victoria lineage viruses in São Paulo, Brazil, 1996-2012: Implications for vaccine composition strategy.
    Paiva TM, Benega MA, Silva DB, Santos KC, Cruz AS, Hortenci MF, Barbieri MT, Monteiro MM, Barbosa HA, Carvalhanas TR.
    J Med Virol; 2013 Nov 18; 85(11):1983-9. PubMed ID: 23926069
    [Abstract] [Full Text] [Related]

  • 37. Discovery of the neutralizing epitope common to influenza B virus victoria group isolates in Japan.
    Nakagawa N, Suzuoki J, Kubota R, Kobatake S, Okuno Y.
    J Clin Microbiol; 2006 Apr 18; 44(4):1564-6. PubMed ID: 16597895
    [Abstract] [Full Text] [Related]

  • 38. Analysis of influenza B virus lineages and the HA1 domain of its hemagglutinin gene in Guangzhou, southern China, during 2016.
    Ye F, Chen XJ, Guan WD, Pan SH, Yang ZF, Chen RC.
    Virol J; 2018 Nov 14; 15(1):175. PubMed ID: 30428893
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Antigenic variants with amino acid deletions clarify a neutralizing epitope specific for influenza B virus Victoria group strains.
    Nakagawa N, Kubota R, Nakagawa T, Okuno Y.
    J Gen Virol; 2001 Sep 14; 82(Pt 9):2169-2172. PubMed ID: 11514726
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.